Synonyms IMP 2, IMP.18P, IMPA2 + [6] |
Introduction Can use myo-inositol monophosphates, scylloinositol 1,4-diphosphate, glucose-1-phosphate, beta-glycerophosphate, and 2'-AMP as substrates. Has been implicated as the pharmacological target for lithium Li(+) action in brain. |
Target |
Mechanism IMPA2 modulators |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date06 Apr 1970 |
Target |
Mechanism IMPA2 modulators |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date01 Mar 2024 |
Sponsor / Collaborator- |
Start Date06 Feb 2024 |
Sponsor / Collaborator- |
Start Date30 Nov 2023 |
Sponsor / Collaborator Region Stockholm [+1] |